No product was returned for evaluation.The ilet logs were reviewed by beta bionics failure investigation department.No product performance issues were identified.If the product is received at a later date, the complaint will be reopened and investigated accordingly.No anomalies were observed.The device history record (dhr) review was completed, and this device passed all manufacturing release criteria for distribution.There were no issues identified that would have impacted this event.
|
On (b)(6) 2023 a beta bionics clinical diabetes specialist (cds) stated she received a report that an ilet patient had a severe hypoglycemic event on (b)(6) 2023.During the afternoon on (b)(6) 2023, at approximately 1:30pm, the ilet pump readings displayed a downward arrow with the patient's blood glucose (bg) levels at 72 mg/dl.The patient did manual bg test, and their readings were actually 51 mg/dl.Shortly after doing the manual bg test, patient experienced a seizure.The patient's wife gave the patient a glucagon shot which brought them back to consciousness.The patient then changed their dexcom g6 continuous glucose monitor (gcm) sensor thinking the issue they experienced was due to incorrect readings from their dexcom.The patient said they have hypopituitarism, and they take supplemental pills, including hydrocortisone, that could be affecting their bg levels.
|